Your browser doesn't support javascript.
loading
Immunization with Small Amyloid-ß-derived Cyclopeptide Conjugates Diminishes Amyloid-ß-Induced Neurodegeneration in Mice.
Mulder, Cornelis K; Dong, Yun; Brugghe, Humphrey F; Timmermans, Hans A M; Tilstra, Wichard; Westdijk, Janny; van Riet, Elly; van Steeg, Harry; Hoogerhout, Peter; Eisel, Ulrich L M.
Afiliación
  • Mulder CK; University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands.
  • Dong Y; University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands.
  • Brugghe HF; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • Timmermans HA; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • Tilstra W; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • Westdijk J; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • van Riet E; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • van Steeg H; National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands.
  • Hoogerhout P; Institute for Translational Vaccinology (Intravacc), Bilthoven, The Netherlands.
  • Eisel UL; University of Groningen, Groningen Institute of Evolutionary Life Sciences, Groningen, The Netherlands.
J Alzheimers Dis ; 52(3): 1111-23, 2016.
Article en En | MEDLINE | ID: mdl-27060957
BACKGROUND: Soluble oligomeric (misfolded) species of amyloid-ß (Aß) are the main mediators of toxicity in Alzheimer's disease (AD). These oligomers subsequently form aggregates of insoluble fibrils that precipitate as extracellular and perivascular plaques in the brain. Active immunization against Aß is a promising disease modifying strategy. However, eliciting an immune response against Aß in general may interfere with its biological function and was shown to cause unwanted side-effects. Therefore, we have developed a novel experimental vaccine based on conformational neo-epitopes that are exposed in the misfolded oligomeric Aß, inducing a specific antibody response. OBJECTIVE: Here we investigate the protective effects of the experimental vaccine against oligomeric Aß1-42-induced neuronal fiber loss in vivo. METHODS: C57BL/6 mice were immunized or mock-immunized. Antibody responses were measured by enzyme-linked immunosorbent assay. Next, mice received a stereotactic injection of oligomeric Aß1-42 into the nucleus basalis of Meynert (NBM) on one side of the brain (lesion side), and scrambled Aß1-42 peptide in the contralateral NBM (control side). The densities of choline acetyltransferase-stained cholinergic fibers origination from the NBM were measured in the parietal neocortex postmortem. The percentage of fiber loss in the lesion side was determined relative to the control side of the brain. RESULTS: Immunized responders (79%) showed 23% less cholinergic fiber loss (p = 0.01) relative to mock-immunized mice. Moreover, fiber loss in immunized responders correlated negatively with the measured antibody responses (R2 = 0.29, p = 0.02). CONCLUSION: These results may provide a lead towards a (prophylactic) vaccine to prevent or at least attenuate (early onset) AD symptoms.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Péptidos Cíclicos / Péptidos beta-Amiloides / Inmunización / Enfermedades Neurodegenerativas Límite: Animals Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Fragmentos de Péptidos / Péptidos Cíclicos / Péptidos beta-Amiloides / Inmunización / Enfermedades Neurodegenerativas Límite: Animals Idioma: En Revista: J Alzheimers Dis Asunto de la revista: GERIATRIA / NEUROLOGIA Año: 2016 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Países Bajos